A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 17200 participants.

Also called NCT06642272

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 17,200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06642272
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06642272. Randomized; no masking; primary purpose treatment. Start 2024-10-10 (actual); primary completion 2028-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
Acronym
APPLE TREE
Condition
Diabetes Mellitus, Type 2
Condition
Heart Failure
Condition
Chronic Kidney Diseases
Intervention (Drug)
Empagliflozin 10 MG
Intervention (Drug)
Dapagliflozin 10 MG
Lead sponsor
Herlev and Gentofte Hospital (class: other)

Record details

Record id
cardio:ct-nct06642272
Content hash
e6e6c6edf86f2d84f0df62b09c9feb9ef7a5ff24c765351fa27f57756c4ecbb4